Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Gradishar, WJ; Moran, MS; Abraham, J; Aft, R; Agnese, D; Allison, KH; Anderson, B; Burstein, HJ; Chew, H; Dang, C; Elias, AD; Giordano, SH ...
Published in: J Natl Compr Canc Netw
June 2022
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2022
Volume
20
Issue
6
Start / End Page
691 / 722
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Female
- Carcinoma, Intraductal, Noninfiltrating
- Breast Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., … Kumar, R. (2022). Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 20(6), 691–722. https://doi.org/10.6004/jnccn.2022.0030
Gradishar, William J., Meena S. Moran, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Bethany Anderson, et al. “Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 20, no. 6 (June 2022): 691–722. https://doi.org/10.6004/jnccn.2022.0030.
Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Jun;20(6):691–722.
Gradishar, William J., et al. “Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 20, no. 6, June 2022, pp. 691–722. Pubmed, doi:10.6004/jnccn.2022.0030.
Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Isakoff SJ, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch M, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Wisinski KB, Young JS, Burns J, Kumar R. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Jun;20(6):691–722.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2022
Volume
20
Issue
6
Start / End Page
691 / 722
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Female
- Carcinoma, Intraductal, Noninfiltrating
- Breast Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis